• Home
  • PR

PR

News

게시물 상세
OliX Signs Agreement with LGC Biosearch Technologies for the Treatment of Androgenic Alopecia
Date : 2021-06-14     View : 513

OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Androgenic Alopecia

 

Learn more: https://www.biospace.com/article/releases/olix-pharmaceuticals-signs-agreement-with-lgc-biosearch-technologies-to-accelerate-production-of-asymmetric-sirna-for-the-treatment-of-androgenic-alopecia/ 

 

Source _ OliX Pharmaceuticals

Prev OliX Pharmaceuticals Announces Results from Preclinical Study of NASH Therapeutic Candidate
Next OliX Pharmaceuticals Subsidiary mCureX Announces Business Agreements to Advance Development of mRNA